Pre-Seed Round Open. Investor Inquiries: esther@cloakbiotech.com
People

Original DARPA researchers.

CLOAK's founding scientists originated the underlying research through the DARPA ReVector Program. Its advisory bench has built and scaled biotechnology and skin-microbiome ventures.

Founding Team

The Team

Esther Vlessing
Esther Vlessing, BSc., MBA
Co-founder & CEO

A two-time founder who previously bootstrapped CEMM, a medtech company, to $30M+ in government contracts with $8M+ in profit. Named a "One to Watch" in RBC's Canadian Women Entrepreneur Awards.

Omar Akbari, PhD
Omar Akbari, PhD
Co-founder & CSO

A global authority on genetic vector control, Omar is a tenured professor with 150+ publications in Nature, Cell, and Science. He co-founded Synvect with backing from the Gates Foundation and served as co-PI on the DARPA ReVector Program behind CLOAK's core technology.

Iliano Coutinho-Abreu, PhD
Iliano Coutinho-Abreu, PhD
Co-founder & Head of R&D

A leader in entomology, mosquito behavior, and olfaction, Iliano has authored 30+ publications in Nature, Cell, and Science. He was the lead researcher on the DARPA ReVector Program and now leads CLOAK's R&D.

Advisors

Advisors

Maria Cho
Maria Cho, BSc., MSc
Advisor, Biomanufacturing & Commercialization

Former CEO of Triplebar Bio and co-founder of Phyla Skincare, a pioneering skin-microbiome company developing bacteriophage-based acne treatments. Maria brings deep expertise in biomanufacturing and commercialization.

Anil Kumar Makkapati, PhD
Anil Kumar Makkapati, PhD
Advisor, Personal Insect Repellent Expert

A medical entomologist and expert in vector-borne disease management, Anil is the former Head of Entomology R&D at Reckitt Benckiser. He has authored peer-reviewed research on mosquito biology and insecticide resistance, and has contributed to WHO vector control initiatives.